| __timestamp | Apellis Pharmaceuticals, Inc. | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 7180000000 |
| Thursday, January 1, 2015 | 13730311 | 6704000000 |
| Friday, January 1, 2016 | 22978599 | 7194000000 |
| Sunday, January 1, 2017 | 40303878 | 9982000000 |
| Monday, January 1, 2018 | 105285576 | 9752000000 |
| Tuesday, January 1, 2019 | 220968770 | 9872000000 |
| Wednesday, January 1, 2020 | 299921000 | 13397000000 |
| Friday, January 1, 2021 | 420869000 | 12245000000 |
| Saturday, January 1, 2022 | 387236000 | 13548000000 |
| Sunday, January 1, 2023 | 354387000 | 30531000000 |
Unleashing insights
In the ever-evolving landscape of pharmaceutical innovation, research and development (R&D) budgets are a critical indicator of a company's commitment to future breakthroughs. Over the past decade, Merck & Co., Inc. and Apellis Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Merck's R&D expenses surged by over 300%, peaking at an impressive $30.5 billion in 2023. This reflects Merck's robust strategy to maintain its leadership in the pharmaceutical industry. In contrast, Apellis, a smaller player, increased its R&D spending by approximately 4,100% during the same period, reaching $354 million in 2023. This rapid growth underscores Apellis's aggressive push to carve out a niche in the competitive market.
These figures highlight the diverse strategies of established giants and ambitious newcomers in the quest for medical innovation.
Analyzing R&D Budgets: Novo Nordisk A/S vs Apellis Pharmaceuticals, Inc.
Comparing Innovation Spending: Merck & Co., Inc. and Bristol-Myers Squibb Company
R&D Insights: How Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc. Allocate Funds
Merck & Co., Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Merck & Co., Inc. vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Bausch Health Companies Inc.
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Wave Life Sciences Ltd.
Comparing Innovation Spending: Merck & Co., Inc. and Galapagos NV
Research and Development Expenses Breakdown: Dr. Reddy's Laboratories Limited vs Apellis Pharmaceuticals, Inc.
Research and Development Investment: Alpine Immune Sciences, Inc. vs Apellis Pharmaceuticals, Inc.
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs CRISPR Therapeutics AG
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.